Sep 30, 2015 FierceBiotech Names Syros Pharmaceuticals as One of Its “Fierce 15” Biotech Companies of 2015
Sep 24, 2015 Syros Pharmaceuticals Announces New Publication Highlighting the Strong Potential of CDK7 Inhibition in Difficult-to-Treat Cancer
Sep 24, 2015 Syros Pharmaceuticals Licenses Clinical-Stage RARα Agonist to Develop and Commercialize for Genomically-Defined Cancer Populations Identified by Gene Control Platform
Apr 15, 2015 Syros Pharmaceuticals to Present New Data from its Gene Control Platform in AML and Breast Cancer at AACR Annual Meeting 2015
Mar 20, 2015 Syros Pharmaceuticals Announces New Research Published on Role of Cell Signaling Pathways in Gene Control